WISI HEALTHY Trademark

Trademark Overview


On Thursday, July 4, 2024, a trademark application was filed for WISI HEALTHY with the United States Patent and Trademark Office. The USPTO has given the WISI HEALTHY trademark a serial number of 79402602. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 8, 2025. This trademark is owned by SAMJIN PHARMACEUTICAL CO., LTD.. The WISI HEALTHY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vitamin and mineral food supplements in tablet, capsule, liquid, jelly, gummy form; vitamin and mineral preparations; vitamins and vitamin preparations; vitamin B preparations; vitamin C preparations; vitamin D preparations; health food supplements made principally of vitamins; nutritive substances for use as a dietary supplement; dietary supplemental drinks; nutraceuticals for use as a dietary supplement; multivitamin preparations; probiotic dietary supplements; mixed vitamin preparations; nutraceutical preparations mainly based on red ginseng for use as a dietary supplement
wisi healthy

General Information


Serial Number79402602
Word MarkWISI HEALTHY
Filing DateThursday, July 4, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vitamin and mineral food supplements in tablet, capsule, liquid, jelly, gummy form; vitamin and mineral preparations; vitamins and vitamin preparations; vitamin B preparations; vitamin C preparations; vitamin D preparations; health food supplements made principally of vitamins; nutritive substances for use as a dietary supplement; dietary supplemental drinks; nutraceuticals for use as a dietary supplement; multivitamin preparations; probiotic dietary supplements; mixed vitamin preparations; nutraceutical preparations mainly based on red ginseng for use as a dietary supplement
NOT AVAILABLEHEALTHY

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMJIN PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, August 22, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, December 28, 2024ASSIGNED TO EXAMINER
Sunday, December 29, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 29, 2025REFUSAL PROCESSED BY MPU
Wednesday, January 29, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 15, 2025REFUSAL PROCESSED BY IB
Friday, August 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2024APPLICATION FILING RECEIPT MAILED
Sunday, December 29, 2024NON-FINAL ACTION WRITTEN
Sunday, March 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, March 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 30, 2025APPROVED FOR PUB - PRINCIPAL REGISTER